AAPL332.27+5.70 (+1.75%) ▲|ABBV257.12+2.12 (+0.83%) ▲|ABT104.20+2.20 (+2.15%) ▲|ACN192.45+8.59 (+4.67%) ▲|ADBE263.36+11.13 (+4.41%) ▲|AMAT421.84-34.65 (-7.59%) ▼|AMD484.37-31.76 (-6.15%) ▼|AMGN380.36+3.01 (+0.80%) ▲|AMT177.54-0.33 (-0.19%) ▼|AMZN254.39-2.40 (-0.93%) ▼|AVGO347.05-14.95 (-4.13%) ▼|AXP326.50+1.82 (+0.56%) ▲|BA209.55-0.78 (-0.37%) ▼|BAC62.35-0.34 (-0.53%) ▼|BKNG180.52+6.60 (+3.79%) ▲|BLK1,075.02-4.57 (-0.42%) ▼|BMY64.64+1.02 (+1.60%) ▲|BNY160.77-1.90 (-1.17%) ▼|BRK-B513.81+3.47 (+0.68%) ▲|C136.63-2.17 (-1.56%) ▼|CAT781.18-37.37 (-4.56%) ▼|CL88.32+1.54 (+1.77%) ▲|CMCSA25.34+0.14 (+0.56%) ▲|COF208.23-0.02 (-0.01%) ▼|COP139.12+1.75 (+1.27%) ▲|COST915.63+10.86 (+1.20%) ▲|CRM255.22+7.57 (+3.05%) ▲|CSCO110.03-2.10 (-1.87%) ▼|CVS95.72+1.05 (+1.11%) ▲|CVX216.90+2.86 (+1.34%) ▲|DE671.51-4.78 (-0.71%) ▼|DHR201.62+1.53 (+0.76%) ▲|DIS108.32+1.78 (+1.67%) ▲|DUK120.28+0.86 (+0.72%) ▲|EMR147.30-4.86 (-3.19%) ▼|FDX312.04+1.26 (+0.40%) ▲|GD357.16+1.25 (+0.35%) ▲|GE312.74-10.87 (-3.36%) ▼|GEV881.50-75.07 (-7.85%) ▼|GILD144.79+1.07 (+0.74%) ▲|GM86.44+0.82 (+0.96%) ▲|GOOG340.45+5.00 (+1.49%) ▲|GOOGL344.02+5.52 (+1.63%) ▲|GS1,008.54-20.57 (-2.00%) ▼|HD310.18+1.45 (+0.47%) ▲|HON199.13-3.23 (-1.60%) ▼|IBM246.04+2.80 (+1.15%) ▲|INTC95.43-7.51 (-7.30%) ▼|INTU339.11+17.54 (+5.45%) ▲|ISRG375.09+5.94 (+1.61%) ▲|JNJ269.57+3.95 (+1.49%) ▲|JPM353.51-2.77 (-0.78%) ▼|KO89.77+1.51 (+1.71%) ▲|LIN464.39-1.83 (-0.39%) ▼|LLY1,134.64+19.41 (+1.74%) ▲|LMT526.57+2.65 (+0.51%) ▲|LOW198.32+1.51 (+0.76%) ▲|LRCX274.44-23.79 (-7.98%) ▼|MA577.58+8.43 (+1.48%) ▲|MCD257.22+4.71 (+1.86%) ▲|MDLZ63.52+1.08 (+1.73%) ▲|MDT93.48+2.50 (+2.75%) ▲|META659.26+11.23 (+1.73%) ▲|MMM162.80-2.15 (-1.31%) ▼|MO70.96+1.99 (+2.89%) ▲|MRK145.72+1.78 (+1.24%) ▲|MS211.07-3.32 (-1.55%) ▼|MSFT496.53+0.90 (+0.18%) ▲|MU904.89-70.38 (-7.22%) ▼|NEE82.51+0.20 (+0.24%) ▲|NFLX79.77+2.37 (+3.06%) ▲|NKE37.12+0.30 (+0.82%) ▲|NOW140.94+8.41 (+6.34%) ▲|NVDA209.12-9.17 (-4.20%) ▼|ORCL141.79-8.36 (-5.57%) ▼|PEP138.52+2.20 (+1.61%) ▲|PFE27.95+0.26 (+0.94%) ▲|PG147.15+1.93 (+1.33%) ▲|PLTR167.08-0.15 (-0.09%) ▼|PM194.68+3.59 (+1.88%) ▲|QCOM176.50-5.48 (-3.01%) ▼|RTX195.71-1.97 (-1.00%) ▼|SBUX99.41+0.67 (+0.68%) ▲|SCHW107.49+0.24 (+0.22%) ▲|SO87.59+0.42 (+0.48%) ▲|SPG206.18+1.35 (+0.66%) ▲|T26.35+0.29 (+1.09%) ▲|TMO612.55+2.55 (+0.42%) ▲|TMUS185.25+2.92 (+1.60%) ▲|TSLA361.18-4.26 (-1.17%) ▼|TXN262.23-6.47 (-2.41%) ▼|UBER71.61-0.06 (-0.08%) ▼|UNH381.93+5.16 (+1.37%) ▲|UNP284.78+0.38 (+0.13%) ▲|UPS101.25+0.97 (+0.96%) ▲|USB62.98+0.14 (+0.22%) ▲|V375.96+5.51 (+1.49%) ▲|VZ51.13+0.52 (+1.03%) ▲|WFC90.13-0.16 (-0.18%) ▼|WMT108.51+1.36 (+1.27%) ▲|XOM168.43+2.44 (+1.47%) ▲|AAPL332.27+5.70 (+1.75%) ▲|ABBV257.12+2.12 (+0.83%) ▲|ABT104.20+2.20 (+2.15%) ▲|ACN192.45+8.59 (+4.67%) ▲|ADBE263.36+11.13 (+4.41%) ▲|AMAT421.84-34.65 (-7.59%) ▼|AMD484.37-31.76 (-6.15%) ▼|AMGN380.36+3.01 (+0.80%) ▲|AMT177.54-0.33 (-0.19%) ▼|AMZN254.39-2.40 (-0.93%) ▼|AVGO347.05-14.95 (-4.13%) ▼|AXP326.50+1.82 (+0.56%) ▲|BA209.55-0.78 (-0.37%) ▼|BAC62.35-0.34 (-0.53%) ▼|BKNG180.52+6.60 (+3.79%) ▲|BLK1,075.02-4.57 (-0.42%) ▼|BMY64.64+1.02 (+1.60%) ▲|BNY160.77-1.90 (-1.17%) ▼|BRK-B513.81+3.47 (+0.68%) ▲|C136.63-2.17 (-1.56%) ▼|CAT781.18-37.37 (-4.56%) ▼|CL88.32+1.54 (+1.77%) ▲|CMCSA25.34+0.14 (+0.56%) ▲|COF208.23-0.02 (-0.01%) ▼|COP139.12+1.75 (+1.27%) ▲|COST915.63+10.86 (+1.20%) ▲|CRM255.22+7.57 (+3.05%) ▲|CSCO110.03-2.10 (-1.87%) ▼|CVS95.72+1.05 (+1.11%) ▲|CVX216.90+2.86 (+1.34%) ▲|DE671.51-4.78 (-0.71%) ▼|DHR201.62+1.53 (+0.76%) ▲|DIS108.32+1.78 (+1.67%) ▲|DUK120.28+0.86 (+0.72%) ▲|EMR147.30-4.86 (-3.19%) ▼|FDX312.04+1.26 (+0.40%) ▲|GD357.16+1.25 (+0.35%) ▲|GE312.74-10.87 (-3.36%) ▼|GEV881.50-75.07 (-7.85%) ▼|GILD144.79+1.07 (+0.74%) ▲|GM86.44+0.82 (+0.96%) ▲|GOOG340.45+5.00 (+1.49%) ▲|GOOGL344.02+5.52 (+1.63%) ▲|GS1,008.54-20.57 (-2.00%) ▼|HD310.18+1.45 (+0.47%) ▲|HON199.13-3.23 (-1.60%) ▼|IBM246.04+2.80 (+1.15%) ▲|INTC95.43-7.51 (-7.30%) ▼|INTU339.11+17.54 (+5.45%) ▲|ISRG375.09+5.94 (+1.61%) ▲|JNJ269.57+3.95 (+1.49%) ▲|JPM353.51-2.77 (-0.78%) ▼|KO89.77+1.51 (+1.71%) ▲|LIN464.39-1.83 (-0.39%) ▼|LLY1,134.64+19.41 (+1.74%) ▲|LMT526.57+2.65 (+0.51%) ▲|LOW198.32+1.51 (+0.76%) ▲|LRCX274.44-23.79 (-7.98%) ▼|MA577.58+8.43 (+1.48%) ▲|MCD257.22+4.71 (+1.86%) ▲|MDLZ63.52+1.08 (+1.73%) ▲|MDT93.48+2.50 (+2.75%) ▲|META659.26+11.23 (+1.73%) ▲|MMM162.80-2.15 (-1.31%) ▼|MO70.96+1.99 (+2.89%) ▲|MRK145.72+1.78 (+1.24%) ▲|MS211.07-3.32 (-1.55%) ▼|MSFT496.53+0.90 (+0.18%) ▲|MU904.89-70.38 (-7.22%) ▼|NEE82.51+0.20 (+0.24%) ▲|NFLX79.77+2.37 (+3.06%) ▲|NKE37.12+0.30 (+0.82%) ▲|NOW140.94+8.41 (+6.34%) ▲|NVDA209.12-9.17 (-4.20%) ▼|ORCL141.79-8.36 (-5.57%) ▼|PEP138.52+2.20 (+1.61%) ▲|PFE27.95+0.26 (+0.94%) ▲|PG147.15+1.93 (+1.33%) ▲|PLTR167.08-0.15 (-0.09%) ▼|PM194.68+3.59 (+1.88%) ▲|QCOM176.50-5.48 (-3.01%) ▼|RTX195.71-1.97 (-1.00%) ▼|SBUX99.41+0.67 (+0.68%) ▲|SCHW107.49+0.24 (+0.22%) ▲|SO87.59+0.42 (+0.48%) ▲|SPG206.18+1.35 (+0.66%) ▲|T26.35+0.29 (+1.09%) ▲|TMO612.55+2.55 (+0.42%) ▲|TMUS185.25+2.92 (+1.60%) ▲|TSLA361.18-4.26 (-1.17%) ▼|TXN262.23-6.47 (-2.41%) ▼|UBER71.61-0.06 (-0.08%) ▼|UNH381.93+5.16 (+1.37%) ▲|UNP284.78+0.38 (+0.13%) ▲|UPS101.25+0.97 (+0.96%) ▲|USB62.98+0.14 (+0.22%) ▲|V375.96+5.51 (+1.49%) ▲|VZ51.13+0.52 (+1.03%) ▲|WFC90.13-0.16 (-0.18%) ▼|WMT108.51+1.36 (+1.27%) ▲|XOM168.43+2.44 (+1.47%) ▲|
21 C
New York
Monday, September 14, 2026

Tag: analysis

newssourceFORcompanyinformationcontent1releasesmarket

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.

Anime Market to Grow at a CAGR of 9.6% from 2025 to 2032 | SkyQuest Technology Consulting

The Anime market is anticipated to increase due to rapidly expanding international fanbase, especially among Gen Z and millennials. Increased accessibility through streaming platforms...

Anime Market to Grow at a CAGR of 9.6% from 2025 to 2032 | SkyQuest Technology Consulting

The Anime market is anticipated to increase due to rapidly expanding international fanbase, especially among Gen Z and millennials. Increased accessibility through streaming platforms...

Hydrogen Peroxide Market is expected to generate a revenue of USD 2.92 Billion by 2032, Globally, at 6.50% CAGR: Verified Market Research®

The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...

Hydrogen Peroxide Market is expected to generate a revenue of USD 2.92 Billion by 2032, Globally, at 6.50% CAGR: Verified Market Research®

The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...

Fireweed Intersects Sulphide Mineralization at Boundary Zone Muon Targets

TSXV: FWZOTCQX: FWEDFFSE: M0G VANCOUVER, BC, July 30, 2025 /CNW/ - Fireweed Metals Corp. ("Fireweed" or the "Company") (TSXV: FWZ) (OTCQX: FWEDF) is pleased to report the...

Exhale Launches Hawaiian Haze & Northern Lights: The New Faces of Premium Delta 8 Flower

Check out Exhale’s new premium Delta 8 flower strains: Hawaiian Haze for euphoria & Northern Lights for relaxation. Best option for balanced highs & therapeutic benefits. 
Check out Exhale’s new premium Delta 8 flower strains: Hawaiian Haze for euphoria & Northern Lights for relaxation. Best option for balanced highs & therapeutic benefits.

Crown Castle Releases 2024 Sustainability Report

HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle" or the "Company") announced today the release of its 2024 Sustainability Report and updates to its sustainability website, which can be found at www.crowncastle.com/sustainability.

OncoHost Named Top Precision Oncology Solution for 2025

BINYAMINA, Israel and CARY, N.C., July 30, 2025 /PRNewswire/ -- OncoHost, a leader in precision oncology leveraging proteomics and AI to personalize cancer care, today...

ETRUSCUS CLOSES FINAL TRANCHE OF FINANCING

VANCOUVER, BC, July 30, 2025 /CNW/ - Etruscus Resources Corp. (CSE: ETR) (OTC: ETRUF) (FSE: ERR) (the "Company" or "Etruscus") announces the Company has closed the...

Capital Power announces second quarter 2025 results

The Company expands and enhances its US flexible generation portfolio with its largest acquisition to date 
The Company expands and enhances its US flexible generation portfolio with its largest acquisition to date

COPPER GIANT EXTENDS MOCOA’S NEAR SURFACE HIGH-GRADE WITH 567-METRES AT 0.54% COPPER & 0.07% MOLYBDENUM

Hole MD-047 returned 1,004-metres of continuous copper and molybdenum mineralization from surface with the entire hole averaging 0.57% CuEq* (0.39% Cu and 0.04% Mo)—highlighting one...

PAN GLOBAL ADVANCES DRILL PROGRAMS AT ESCACENA AND CÁRMENES PROJECTS, SPAIN

TSXV: PGZ   |   OTCQB: PGZFF   |   FRA: 2EU   Multi-target drill program in progress at Escacena, testing VMS-associated copper, tin, silver, gold targetsDrill program in progress...

PAN GLOBAL ADVANCES DRILL PROGRAMS AT ESCACENA AND CÁRMENES PROJECTS, SPAIN

TSXV: PGZ   |   OTCQB: PGZFF   |   FRA: 2EU   Multi-target drill program in progress at Escacena, testing VMS-associated copper, tin, silver, gold targetsDrill program in progress...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAnalysis

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers